ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7 | -99.8% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -94.6% | 2,000 | -97.1% | 0.00% | -100.0% |
| Q4 2021 | $74,000 | -1.3% | 70,122 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $75,000 | -45.7% | 66,222 | -49.0% | 0.00% | -50.0% |
| Q2 2021 | $138,000 | -6.1% | 129,881 | -13.8% | 0.01% | -14.3% |
| Q1 2021 | $147,000 | +600.0% | 150,743 | +208.6% | 0.01% | – |
| Q4 2020 | $21,000 | +110.0% | 48,850 | -4.4% | 0.00% | -100.0% |
| Q3 2020 | $10,000 | +150.0% | 51,100 | +5577.8% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 900 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |